English
中文 (香港)
About AFCR
Mission
Our Team
Council Members and Advisors
Reports
Our Partners
FAQs
Contact Us
Research Program
Basic Research
Translational Research
Clinical Research
BRACE Award
Global Summit
Women in Cancer Research
Young Investigator Award
Cancer Facts
AFCR News
Ways to Give
Donate Now
Donate Monthly
Gifts In Memory
Gifts in Honor
Contact Us
Blog
Keyhole surgery a ‘better approach’ for women with early stage womb cancer
Anne Li …...
Read more
‘Unacceptable’ cancer treatment waiting times condemned as Scottish targets missed again
Anne Li April…...
Read more
Recommendations set out for food industry to reduce sugar
Anne Li April…...
Read more
NHS England sets target of 5,000 more people each year surviving cancer
Anne Li April…...
Read more
News digest – cutting sugar, a new NHS target, lab-grown mini tumours, and… vitamin C as a treatment?
Anne Li April…...
Read more
6 Steps to Help Lower Your Cancer Risk
Anne Li April…...
Read more
Transitioning Back to Life After Treatment Is a Challenge for Many Cancer Survivors
Anne Li April…...
Read more
Breaking Down Health Care Barriers for LGBT Community
Anne Li April…...
Read more
Minority Cancer Awareness: What Everyone Should Know
Anne Li April…...
Read more
FDA Approves Zejula (Niraparib) for Ovarian Cancer
Anne Li April…...
Read more
76
77
78
79
80
81
82
83
84
85
86
87
88
Sign Up for AFCR’s Newsletter
Notice: JavaScript is required for this content.
×
Your ticket for the: FDA Approves Zejula (Niraparib) for Ovarian Cancer
Title
FDA Approves Zejula (Niraparib) for Ovarian Cancer
USD
